skip to main content
Idioma:
Refinado por: Nome da Publicação: Atherosclerosis remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hepatic CETP expression is lowered by cholestyramine or lovastatin administration to human CETP transgenic and LDL receptor knock out heterozigous mice
Hepatic CETP expression is lowered by cholestyramine or lovastatin administration to human CETP transgenic and LDL receptor knock out heterozigous mice
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Hepatic CETP expression is lowered by cholestyramine or lovastatin administration to human CETP transgenic and LDL receptor knock out heterozigous mice

Alexandre José Faria Carrilho Lila Mina Harada; M Passarelli; Wilson Luvizotto Medina; H. C. F Oliveira; Edna Regina Nakandakare; L. B Agellon; Eder Carlos da Rocha Quintão; Congress of the European Atherosclerosis Society (71. 1999 Athens)

Atherosclerosis Amsterdam v. 144, supl., p. 166, 1999

Amsterdam Elsevier 1999

Item não circula. Consulte sua biblioteca.(Acessar)

2
N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1
N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1
Material Type:
Artigo 		Adicionar ao Meu Espaço

N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1

Juliana T. Machado Rodrigo T Iborra; Fernanda B Fusco; Gabriela Castilho; Raphael S Pinto; Adriana Machado-Lima; Edna R Nakandakare; Antonio C Seguro; Maria H Shimizu; Sergio Catanozi; Marisa Passarelli

Atherosclerosis Amsterdam v. 237, n. 1, p. 343-352, 2014

Amsterdam 2014

Localização: FM - Fac. Medicina    (BCSEP 061 2014 )(Acessar)

3
In type 1 diabetes mellitus impaired vascular function relates to the expression of MYD88 in lymphomononuclear cells but not to dietary advanced glycation end-products
In type 1 diabetes mellitus impaired vascular function relates to the expression of MYD88 in lymphomononuclear cells but not to dietary advanced glycation end-products
Material Type:
Artigo 		Adicionar ao Meu Espaço

In type 1 diabetes mellitus impaired vascular function relates to the expression of MYD88 in lymphomononuclear cells but not to dietary advanced glycation end-products

Toyoshima, M.T.K. ; Santos-Bezerra, D.P. ; Machado-Lima, A. ; Goes, M.F.S. ; Caramelli, B. ; Correa-Giannella, M.L.C. ; Passarelli, M.

Atherosclerosis, 2018-08, Vol.275, p.e63-e63 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.